A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia

JL Harousseau, JE Lancet, J Reiffers, Bob Löwenberg, X Thomas, F Huguet, P Fenaux, S Zhang, W Rackoff, P De Porre, R Stone

Research output: Contribution to journalArticleAcademicpeer-review

70 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)5151-5156
Number of pages6
Issue number12
Publication statusPublished - 2007

Cite this